Floating Therapy for PTSD
(FLOAT Trial)
Trial Summary
The trial does not specify if you need to stop taking your current medications, but you cannot use psychoactive drugs or laxatives within a week before the float, and you should avoid recreational drugs, certain antihistamines, and alcohol the day of the float.
Floating Therapy for PTSD is unique because it involves a sensory deprivation experience where patients float in a tank filled with saltwater, reducing external stimuli and promoting deep relaxation, unlike traditional therapies that often involve talk therapy or exposure to trauma-related cues.
12345Eligibility Criteria
This trial is for adults aged 18-60 with PTSD confirmed by the PCL-5. It's not for those with fresh tattoos, skin conditions, history of severe neurological issues, psychotic disorders, or who have floated before. Participants must be English-speaking and agree to a Pre-Float Checklist and Liability Waiver.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants have 3 Floatation sessions that last up to 90 minutes each, spaced about a week apart
Follow-up
Participants are monitored for changes in PTSD symptom severity and other psychological and physiological measures
Participant Groups
Floatation-based REST is already approved in United States, Canada, European Union for the following indications:
- Anxiety
- Depression
- PTSD
- Anxiety
- Depression
- PTSD
- Anxiety
- Depression
- PTSD